ARCHIVES

Drugs and Targets: FDA extends Lymphoseek label to include mapping in solid tumors

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Race, Age Play Role In Delay Of Surgery For Breast Cancer

December 28, 2007

Study Links Obesity To Higher Risk of Ovarian Cancer

January 30, 2009

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

March 16, 2007

In Brief: SSO Plan Session On Grantmanship; Meeting On Free Standing Cancer Centers Is Postponed

May 2, 1986

“Honor Roll” Of Top Investigators Who Won’t Be Funded Because Of Cuts

March 8, 1985

William Tipping New ACS Executive VP; Murphy To Replace Holleb, Laszio Takes Rauscher’s Position

March 4, 1988